Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.
Content updated: 2026-11-22 21:59:51
- Yesterday's Close
- $166.37
- Today's Open
- $168.69
- Today's High
- $169.97
- Today's Low
- $165.63
- Volume
- 8.87M shares
- 52-Week Range
- $122.41-$176.91
As of 2026-11-22 21:59:51, Gilead Sciences Inc (GILD) was quoted at $165.86, a change of -$0.51 (-0.30%) from the previous close. The day's range was $165.63–$169.97, and the 52-week range was $122.41–$176.91.
Why Is Gilead Sciences Inc (GILD) Stock Falling?
AI Stock Price AnalysisContent updated: 2026-11-20 20:50:07
GILD fell 1.44% from a prior close of $168.96 to $166.53 and weakened steadily after opening at $169.16, finishing below its volume-weighted average price (VWAP) of $166.95. The clearest recent company news was expanded voluntary licensing for investigational Ebola drug Obeldesivir, yet full-day volume ran at only 0.60 of baseline, leaving the decline without volume confirmation.
About Gilead Sciences Inc (GILD)
- Ticker / Exchanges
- GILD / NASDAQ
- Industry / Sector
- Drug Manufacturers - General / Healthcare
- CEO
- Daniel O'Day
- Headquarters
- Foster City,CA,US
- Official Website
- https://www.gilead.com
- Listing Date
- 1992-01-22
Recent Company Events
- 2027-02-09Earnings Report · ExpectedOn 2027-02-09, the 2026/Q4 earnings report is expected to be released.
Gilead Sciences Inc (GILD) Derivatives Trading
Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.
Contracts based on stock prices, with no expiration date. They support 24/7 long, short, and leveraged trading without holding the underlying shares. Be aware of funding fees and liquidation risk.
Gilead Sciences Inc (GILD) Company Financials
Valuation and Shares
- Market Cap
- $206.46B
- P/E Ratio (TTM)
- -53.17
- P/B Ratio
- 15.83
- Shares Outstanding
- 1.24B shares
- Float Shares
- 1.23B shares
- Dividend Yield (TTM)
- 1.95%
Latest Reported Financials
2026 Q3 FinancialsReport Release Date: 2026-10-29
Operating Revenue (Actual)
$8.30B
Same Period Last Year: +6.83%
Earnings per Share (Actual)
$2.55
Same Period Last Year: +3.24%
Financials · Actuals
| Actual Value | 2022/Annual | 2023/Annual | 2024/Annual | 2025/Annual |
|---|---|---|---|---|
| Revenue | $27.28B | $27.11B | $28.75B | $29.44B |
| Net Profit | $4.59B | $5.66B | $480.00M | $8.51B |
| Operating Cash Flow | $9.07B | $8.00B | $10.82B | $10.01B |
GILD FAQ
What is the current stock price of Gilead Sciences Inc (GILD)?
Which exchange is GILD listed on?
How has Gilead Sciences Inc stock performed over the past month?
What is the market cap of Gilead Sciences Inc?
What are Gilead Sciences Inc's latest financial results?
What factors may affect the stock price of Gilead Sciences Inc (GILD)?
Other Trading Markets
Risk Warning
Disclaimer







